Scarica l'app Stockscreener
6.63
5.07%
0.32
Dopo l'orario di chiusura:
6.63
Precedente Chiudi:
$6.31
Aprire:
$6.4
Volume 24 ore:
5,026
Relative Volume:
0.20
Capitalizzazione di mercato:
$10.13M
Reddito:
$22.03M
Utile/perdita netta:
$-19.91M
Rapporto P/E:
-0.3581
EPS:
-18.5136
Flusso di cassa netto:
$-16.84M
1 W Prestazione:
+3.76%
1M Prestazione:
-10.41%
6M Prestazione:
-22.36%
1 anno Prestazione:
-67.50%
Intervallo 1D:
$6.30
$6.63
Intervallo di 1 settimana:
$6.08
$6.645
Portata 52W:
$4.14
$21.78
Lifeward Ltd Stock (LFWD) Company Profile
Nome
Lifeward Ltd
Settore
Industria
Telefono
15082511154
Indirizzo
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.63 | 9.64M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Iniziato | Laidlaw | Buy |
| 2017-04-03 | Downgrade | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Iniziato | Oppenheimer | Outperform |
| 2016-07-15 | Iniziato | Piper Jaffray | Overweight |
| 2015-05-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Reiterato | Barclays | Equal Weight |
| 2014-10-07 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Lifeward Ltd Borsa (LFWD) Ultime notizie
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - TipRanks
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - in.investing.com
Lifeward regains Nasdaq compliance after audit committee appointments - Investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - stocktitan.net
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - stocktitan.net
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - stocktitan.net
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - stocktitan.net
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - stocktitan.net
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - stocktitan.net
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - stocktitan.net
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com
If You Invested $1,000 in Lifeward Ltd (LFWD) - stocktitan.net
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - TradingView
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - gurufocus.com
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Lifeward Q4 2025 Earnings Call Transcript - MarketBeat
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Lifeward Ltd Azioni (LFWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifeward Ltd Azioni (LFWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jasinski Lawrence J | Chief Executive Officer |
May 21 '25 |
Sale |
1.26 |
1,909 |
2,405 |
98,728 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):